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BACKGROUND: The timing of puberty is highly sensitive to environmental factors, including endocrine disruptors. Among them, bisphenol A (BPA)
has been previously analyzed as potential modifier of puberty. Yet, disparate results have been reported, with BPA advancing, delaying, or being neu-
tral in its effects on puberty onset. Likewise, mechanistic analyses addressing the central and peripheral actions/targets of BPA at puberty remain
incomplete and conflictive.
OBJECTIVE: We aimed to provide a comprehensive characterization of the impact of early BPA exposures, especially at low, real-life doses, on the
postnatal development of hypothalamic Kiss1/NKB neurons, and its functional consequences on female pubertal maturation.
METHODS: Pregnant CD1 female mice were orally administered BPA at 5, 10, or 40 lg=kg body weight (BW)/d from gestational day 11 to postnatal
day 8 (PND8). Vaginal opening, as an external marker of puberty onset, was monitored daily from PND19 to PND30 in the female offspring. Blood
and brain samples were collected at PND12, 15, 18, 21, and 30 for measuring circulating levels of gonadotropins and analyzing the hypothalamic
expression of Kiss1/kisspeptin and NKB.
RESULTS: Perinatal exposure to BPA, in a range of doses largely below the no observed adverse effect level (NOAEL; 5 mg=kg BW/d, according to
the FDA), was associated with pubertal differences in the female progeny compared with those exposed to vehicle alone, with an earlier age of vagi-
nal opening but consistently lower levels of circulating luteinizing hormone. Mice treated with BPA exhibited a persistent, but divergent, impairment
of Kiss1 neuronal maturation, with more kisspeptin cells in the rostral (RP3V) hypothalamus but consistently fewer kisspeptin neurons in the arcuate
nucleus (ARC). Detailed quantitative analysis of the ARC population, essential for pubertal development, revealed that mice treated with BPA had
persistently lower Kiss1 expression during (pre)pubertal maturation, which was associated with lower Tac2 (encoding NKB) levels, even at low doses
(5 lg=kg BW/d), in the range of the tolerable daily intake (TDI), recently updated by the European Food Safety Authority.
CONCLUSIONS: Our data attest to the consistent, but divergent, effects of gestational exposures to low concentrations of BPA, via the oral route, on
phenotypic and neuroendocrine markers of puberty in female mice, with an unambiguous impact on the developmental maturation not only of Kiss1,
but also of the NKB system, both essential regulators of puberty onset. https://doi.org/10.1289/EHP5570
Introduction
The onset of puberty is a robust developmental trait that depends
on the proper functional organization of the reproductive neuroen-
docrine system, also termed the hypothalamic–pituitary–gonadal
(HPG) axis, at earlier stages of maturation. This intricate process
starts in utero and progresses throughout postnatal development
and is highly influenced by the dynamic interplay between genes
and environment (Tena-Sempere 2010). When this delicate inter-
play is disrupted, the maturation of the HPG axis is altered and
perturbation of the timing of puberty can occur, often as the first
phenotypic sign of later reproductive disorders. Interestingly, dif-
ferent epidemiological studies have identified an advancement of
the age of puberty onset, especially in girls, with younger cohorts
starting puberty earlier (Aksglaede et al. 2009a, 2009b; Euling et al.
2008a; Parent et al. 2016). For instance, the Copenhagen puberty
study reported an advancement of approximately 1 y in the mean
age of thelarche in two cohorts of girls born and studied 15 y apart,
between the early 1990s and 2006 (Aksglaede et al. 2009b). Given
the similar genetic background and the short time elapsed, these
observations support a key role of environmental factors in this
phenomenon, as highlighted by various consensus reports (Buck
Louis et al. 2008; Euling et al. 2008b). Indeed, the escalating prev-
alence of child obesity has been blamed as major contributor for
this trend (Reinehr and Roth 2019). However, body mass index
alone does not likely account for all the environmental contribution
to the advancement of the age of puberty, which seemingly include
also the effects of different endocrine-disrupting compounds
(EDCs) (Castellano and Tena-Sempere 2016; Euling et al. 2008b;
Özen andDarcan 2011; Parent et al. 2015).
Among EDCs, BPA is one of the most widely studied. BPA is
an organic compound with estrogenic activity used in the produc-
tion of polycarbonate plastics and epoxy resins (Vandenberg et al.
2007). BPA is present in many common products, including food
and beverage containers, plastic eating utensils, toys and office
products (Viñas et al. 2012). BPA is currently considered among
the most important chemicals to be managed in terms of environ-
mental health (Kot-Wasic et al. 2007; Petrović et al. 2003). This is
mainly due to its increasing production, with more than 3.6 million
tons/year (Rubin 2011), and its potential involvement in a wide
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array of health problems, including reproductive disorders related
to altered maturation or function of the HPG axis (Dickerson et al.
2012; Patisaul et al. 2009; Rubin et al. 2001;Welshons et al. 2006).
Regardless, the impact of BPA on puberty onset remains conten-
tious. In female rodents, pre- and postnatal BPA exposure has been
associated with either a normal or precocious age of vaginal open-
ing (VO), considered to be an external index of puberty onset,
depending on the timing, dose, and route of administration
(Adewale et al. 2009; Fernández et al. 2009; Honma et al. 2002;
Nikaido et al. 2004; Parent et al. 2015). Moreover, a recent study,
involving subcutaneous administration of various of doses of BPA,
suggested that postnatal exposure to very low doses of BPA
[25 ng=kg body weight (BW)/d] delayed puberty onset in rats,
whereas postnatal injections of very high doses (5 mg=kg BW/d)
tended to advance the onset of puberty (Franssen et al. 2016). In
the same vein, contradictory findings have also been reported in
girls, where some studies have suggested an association between
increased urinary levels of BPA and altered puberty (Durmaz et al.
2014, 2018; Kasper-Sonnenberg et al. 2017; McGuinn et al. 2015)
and other studies have failed to detect changes in pubertal timing
linked to BPA excretion (Buluş et al. 2016; Lee et al. 2014).
Despite numerous phenomenological studies, the mechanisms
whereby BPA exposure might impact the timing of puberty in
females remain poorly understood. Although initial studies sug-
gested the involvement of peripheral mechanisms (Adewale et al.
2009; Nah et al. 2011; Nikaido et al. 2004), recent reports,
involving the use of rodent models exposed to different doses of
BPA, have highlighted the relevance of central neuroendocrine
mechanisms (Franssen et al. 2016; Losa et al. 2011; Naulé et al.
2014; Oliveira et al. 2017; Roepke et al. 2016). In this context,
compelling, but as yet incomplete, evidence has suggested a path-
ogenic role for the hypothalamic kisspeptin system as a potential
target and mediator for the disrupting neuroendocrine actions of
BPA on female pubertal development (Castellano and Tena-
Sempere 2016; Patisaul 2013).
Kisspeptins, a family of structurally related peptides encoded
by the Kiss1 gene, are considered essential regulators of key
aspects of reproductive function (Navarro and Tena-Sempere
2011; Pinilla et al. 2012). Kisspeptins play an essential role in the
activation of the HPG axis at puberty (Tena-Sempere 2013;
Terasawa et al. 2013). This is based on different studies showing
that a) inactivating mutations of either KISS1 or KISS1R, which
encodes the canonical receptor for kisspeptins, cause a lack of
pubertal maturation; b) kisspeptin tone and sensitivity increase
along pubertal development; and c) the number of kisspeptin neu-
rons and their projections to gonadotropin-releasing hormone
(GnRH) neurons increase during the juvenile–pubertal transition
(Pinilla et al. 2012). Importantly, neuroanatomical studies have
shown the existence of two major populations of kisspeptin neu-
rons that are differently regulated by sex steroids (Clarkson et al.
2009b; Pinilla et al. 2012). One of these populations is located in
the rostral preoptic area of the third ventricle (RP3V) and
responds to estrogen with an increased synthesis of kisspeptin. In
contrast, the other population is located in the arcuate nucleus
(ARC) and responds to estrogen with the inhibition of kisspeptin
production (Marraudino et al. 2018; Smith et al. 2005a, 2005b).
ARC kisspeptin neurons co-express neurokinin B (NKB), a
tachykinin peptide encoded by the TAC3/Tac2 gene (Lehman
et al. 2010; Navarro et al. 2011). The release of NKB from these
neurons, which are profusely interconnected and are termed
KNDy because they also express dynorphin (i.e., they produce
kisspeptins, NKB and dynorphin), can activate their kisspeptin
output and, in this way, modulate GnRH neurosecretory activity
(Navarro et al. 2011; Ramaswamy et al. 2010; Wakabayashi et al.
2013). In good agreement, it has been shown that expression of
Tac2 increased earlier than Kiss1 during postnatal development
in mice (Gill et al. 2012) and that NKB stimulated kisspeptin in
male mice during the prepubertal period (Navarro et al. 2011),
thus suggesting the potential role of NKB in the pubertal activa-
tion of kisspeptin–GnRH secretion.
The possibility that BPA might alter the maturation of the
HPG axis in females by disrupting the hypothalamic kisspeptin
system has been suggested by a limited number of studies that
documented that neonatal injections of high doses of BPA signifi-
cantly decreased a) Kiss1 mRNA expression at the RP3V in in-
fantile female rats (Cao et al. 2012); b) the hypothalamic levels
of Kiss1 mRNA in peripubertal female rats (Navarro et al.
2009b); and c) the number of kisspeptin fibers in the ARC of
adult female rats (Patisaul et al. 2009). However, a comprehen-
sive characterization of the impact of early BPA exposure, espe-
cially at low, environmentally relevant doses, on the postnatal
development of hypothalamic Kiss1/NKB neurons and its func-
tional consequences in terms of pubertal maturation of the female
HPG axis is totally missing. Here, we explore the consequences
of perinatal exposure to a wide range of doses of BPA, relevant
in terms of environmental exposure and route of administration,
on the infantile, juvenile, and pubertal development of hypothala-
mic Kiss1/NKB neurons in female mice and correlate such
changes with relevant functional markers of pubertal onset such
as the age of VO, which reflects the rise of ovarian estrogens and
antecedes the first ovulation, as well as the developmental pattern
of gonadotropin secretion.
Methods
Animals and Experimental Design
All experimental procedures involving the use of laboratory
rodents were carried out according to the European Union regula-
tions (EU 2010), current Italian legislation (DL 26/2014), and the
institutional guidelines on animals’ welfare of the University
of Turin. Experiments were approved by the ethical committee of
the University of Turin and designed to minimize the number of
animals used.
Forty adult CD1 female mice (12-week-old) mice bred in the vi-
variumof theUniversity of Turinwere used as dams forBPA admin-
istration. A graphical presentation of the experimental design is
shown in Figure S1. Animals weremaintained under constant condi-
tions of light (12-h light/dark cycle) and temperature (22–23°C), and
housed in 45× 25× 15-cmBPA-free polypropylene cages in groups
of three to fourmice per cage with free access to food andwater. The
standard mouse chow, 4RF25-GLP (Mucedola S.R.L.), with certi-
fied nondetectable estrogenic activity, was used. During a pre-
experimental phase of 10 d, animals with adequate weight gain and
without clinical abnormalities were trained to spontaneously drink
tocopherol-stripped corn oil (Sigma-Aldrich) through a nonstressful
procedure (Palanza et al. 2002). Briefly, a micropipette tip was
placed into the mouse mouth with the pipette tip gently touching
the roof of the mouth, and the oil was ejected from the pipette.
The mice readily consumed the oil. After this period, female
mice were housed between cages of males to induce ovulation
and then paired with CD1 male mice for up to a week. Mating
was verified by the presence of a vaginal plug, which was consid-
ered gestational day 0 (GD0).
After mating, pregnant females were housed singly and were
randomly divided into four experimental treatment groups (n=10
pregnant mice per group): OIL, receiving only the vehicle (corn
oil); BPA 5, 10, and 40, receiving 5, 10, and 40 lg=kg BW/d of
BPA (BPA purity 99%; SIGMA-Aldrich), respectively. Dosing
solutions were freshly prepared and adjusted to mouse weight
(final volume: 30 lL). Treatments were orally administered daily
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fromGD11 to postnatal day 8 (PND8). Oral dosage was selected to
mimic human exposure routes to BPA (Arambula et al. 2016;
Rebuli et al. 2014). The indicated age-window of BPA exposure
was selected to cover the critical period of prenatal brain organiza-
tion, starting from GD10–11 (Howdeshell 2002) and the postnatal
period of organization of hypothalamic sexually dimorphic circuits
in rodents (Toran-Allerand 1976).
Within 12 h of birth, litters were weighted, sexed, and culled to
10 pups (5± 1 males and 5± 1 females) and returned to their
mother. In total, 40 litters were generated. Due to logistic reasons
related to the large number of litters/animals being handled simul-
taneously and given our primary interest on the physiological and
environmental determinants of female puberty, the experiments
were performed selectively in female mice. Hence, subsets of
female mice were euthanized at the following age points of early
postnatal development: PND12, 15, 18, 21, and 30, for hormonal,
in situ hybridization (ISH), and immunohistochemical (IHC) anal-
yses. Given the differential processing of brain tissues for ISH and
IHC (see below), for each age point and BPA treatment, 10 female
mice were euthanized and allocated for ISH and IHC procedures
(n=5=each). For PND30, larger groups, of 15 mice each, were
generated for monitoring the age of VO. Allocation of pups to each
age point of samplingwas conducted randomly. However, to avoid
any potential litter effect, only one pup per litter was included in
each experimental group, as defined by the age of sampling and
dose of BPA.
The rationale for selection of the different age points for blood
and brain sampling was as follows. PND12 was chosen as repre-
sentative of the infantile period, when sex differences in the pattern
of hypothalamic Kiss1mRNA expression start to emerge (Semaan
et al. 2010). Later age points were selected because they cover the
transition from the late-infantile to the juvenile period, between
PND15 and 21, corresponding to the third week of postnatal life,
when clear changes in Kiss1/kisspeptin expression become fully
detectable in female rodents (Clarkson and Herbison 2006). An
additional age point (PND30), corresponding to the pubertal pe-
riod,was also included (Clarkson andHerbison 2006). As a general
procedure for termination of experiments, the animals were anes-
thetized and euthanized in the morning (at 1000 hours), either by
direct decapitation (for ISH) or after perfusion (for IHC), at the age
points indicated above. Trunk blood samples were collected, cen-
trifuged for serum isolation and stored at −20C for hormonal
determinations.
For the PND30 groups, weaning was conducted at PND21,
when female pups of the same group of treatment were housed in
single mouse cages with free access to food and water. In these
mice, VO, considered to be an external sign of puberty onset, was
monitored daily from PND19 to 30, in OIL- and BPA-treated mice
(n=15=group). VO was considered positive only when complete
canalization of the vagina was confirmed upon visual inspection,
following standard protocols (Gaytan et al. 2017). Considering our
experimental design, with the latest age point being PND30, and
the fact that in mice, first estrus usually occurs around 7 d after VO
(Gaytan et al. 2017), we decided not to obtain vaginal smears for
detection of cytological signs of first ovulation given that this
would have occurred several days after PND30. This procedure
minimized manipulation, and potential interference, of the experi-
mental animals.
Hormonal determinations were conducted for each age point
and treatment in samples from 6–10 independent mice, whereas
ISH and IHC analyses were applied in brain sections from at least
5 different mice. These numbers of individual determinations are
in line with previously published studies analyzing analogous pa-
rameters (Arambula et al. 2016; Navarro et al. 2009b) and,
according to statistical power calculations (G*Power; University
of Dusseldorf, Germany), were anticipated to be sufficient to reli-
ably detect differences, with statistical significance (p<0:05), for
the hormonal [n=6–10; luteinizing hormone (LH) and follicle-
stimulating hormone (FSH)], mRNA (n=5; Kiss1 and Tac2),
and protein (n=5; kisspeptin) end points being analyzed.
Kisspeptin Immunohistochemistry and Quantitative Analysis
For IHC analyses, female mice (n=5 from each of the OIL or the
BPA groups, at the various age points between PND12 and 30)
were deeply anesthetized with 2,2,2-tribromoethanol [250 mg=kg
intraperitoneal (i.p.); SIGMA-Aldrich] and perfused first with
0.9% saline solution until bloodwas flushed, followed by perfusion
with fixative solution (4% formaldehyde in 0:1 M phosphate
buffer, pH 7.4). Brains were dissected, post-fixed overnight in the
samefixative, and stored in 30% sucrose–phosphate buffered saline
(PBS) solution for 2–4 d at 4°C. Brains were frozen in a dry ice/iso-
pentane bath at −35C and four sets of 25-lm-thick coronal sec-
tions were cut containing the Anteroventral Periventricular Nucleus/
Periventricular Nucleus (AvPV/PeN) and the ARC nuclei, respec-
tively, and kept as free-floating sections in antifreeze solution at
−20C. The plain of sectioning matched the drawings corre-
sponding to the coronal sections of the mouse brain atlas
(Paxinos and Franklin 2001). All sections were processed simul-
taneously, and the individual slides were coded to blind the treat-
ment for the evaluator.
Brain sections were processed for the avidin–biotin immunohis-
tochemical method, according to previous references (Franceschini
et al. 2006). Briefly, after overnight rinsing in 0:01 M PBS, sections
were exposed to Triton X-100 (0.2% in PBS), treated in 1%metha-
nol/hydrogen peroxide solution for 20 min to block endogenous
peroxidase activity, then incubated for 30 min with normal goat
serum (Vector Laboratories). Sections were then incubated at
4°C for 24 h with a polyclonal rabbit antiserum AC#566 against
rodent kisspeptin-10, diluted 1:10,000, as previously defined
(Clarkson and Herbison 2006; Franceschini et al. 2006). The anti-
bodyAC#566, used for immunohistochemical detection of kisspep-
tin, was a generous gift from I. Franceschini (Nouzilly, France).
After washing in PBS, the sectionswere incubated for 60min in bio-
tinylated secondary goat anti-rabbit IgG (Vinci), washed, and incu-
bated for 60 min with the avidin–biotin complex (VECTASTAIN®
Elite® kit; Labtek). Finally, theywere incubated in 0:15 mg=mLdia-
minobenzidine (DAB; SIGMA-Aldrich), and 0.025%hydrogen per-
oxide in 0:05 MTris-HCl buffer (pH 7.6) for 5min and thenwashed
twice in distilled water and PBS. The free-floating brain sections
weremounted on chrom-alum coated slides, air dried, washed in xy-
lene, and cover-slipped in Entellanmountingmedium (Merck).
For quantitative analysis of kisspeptin-immunoreactive (Kp-
IR) cell bodies and fibers, we selected two hypothalamic areas:
RP3V (Bregma 0.50 to 0.02) and ARC (Bregma −1:46 to −1:70).
A variable number of standardized sections of comparable levels
were chosen for each nucleus: four for ARC, and six for RP3V.
Selected levels were digitized with a NIKON Digital Sight system
connected to a NIKON Eclipse 80i microscope (Nikon Italia
S.p.S.), by using a 10× (RP3V) or a 20× (ARC) objective. Digital
images were processed and analyzed by means of a freeware
(ImageJ 1.42q; Schneider et al. 2012). Total measurements were
performed within predetermined areas [areas of interest (AOIs)].
The AOI selected for each nucleus was a box of fixed size and
shape, selected to cover positive material only within the bounda-
ries of each nucleus (∼ 600:000lm2 for RP3V, and 280.000 for
ARC). Kp-IR structures, both cell bodies and processes, were
measured by calculating, in binary transformations of the images
(the threshold function of the software), the fractional area, defined
as the percentage of pixels covered by immunoreactive elements.
Due to differences in the immunostaining, the range of the
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threshold was individually adjusted for each section. In line with our
previous studies (Marraudino et al. 2018; Panzica et al. 2011), the
Kp-IR cell bodies were clearly visible only in the RP3V, whereas
they were not clearly discernible in theARC due to dense fiber accu-
mulation. Therefore, the number of Kp-IR cell bodies was measured
only in the RP3V, by the Cell Counter plugin of ImageJ, and
expressed as total number of cells in the reference area. The analyses
were performed blindedwith regard to treatment group.
Detection of Kiss1 and Tac2 mRNA Expression by in Situ
Hybridization
Female mice exposed to OIL or the range of BPA doses were anes-
thetized with an i.p. injection of chloral hydrate (400 mg=kg) and
euthanized by decapitation in the morning (at 1000 hours), at the
age points indicated above (PND12, 15, 18, 21, and 30; n=5 ani-
mals per BPA dose and age). Upon decapitation, brain samples
were collected on dry ice and stored at −80C until processed for
analysis of Kiss1 and Tac2mRNA expression using ISH. Five sets
of 20-lm sections in the coronal plane were cut on a cryostat from
the diagonal band of Broca to the mammillary bodies, thaw-
mounted onto SuperFrost™ Plus slides (VWR Scientific), and
stored at−80C.
To quantitatively assess Kiss1 and Tac2 mRNA levels, ISH
procedures were performed in hypothalamic tissues, with special
attention to the analysis of the regions comprising most of the
expression of Kiss1 (ARC and RP3V) and Tac2 (ARC). For
detection of mouse Kiss1 mRNA, a specific antisense riboprobe
(5´-ACCTGCCTCCTGCCGTAGCG-3´) located between nucle-
otides 352 and 371 of the circular DNA (cDNA) sequence
(GenBank accession no. AF472576) was used. In the case of
Tac2 mRNA, the specific antisense riboprobe (5´-ATTTGAGGA-
TGCCAAAGCTG-3´) is located between nucleotides 444 and 463
of the cDNA sequence (GenBank accession no. NM_009312).
Single-Label ISH of Kiss1 and Tac2 mRNA
Radiolabeled Kiss1 and Tac2mRNA probes were transcribed using
T7 polymerase (Bio-Rad Laboratories) and Kiss1 or Tac2 cDNA
templates containing the T7 polymerase region, as described previ-
ously (Ruiz-Pino et al. 2012; Sánchez-Garrido et al. 2014, 2015).
Briefly, radiolabeled RNA probes were synthesized by adding the
Figure 1. Impact of perinatal exposure to a range of doses of BPA on the age of VO and the pattern of gonadotropin secretion. Female mice exposed to
increasing doses of BPA: 5, 10, or 40 lg=kg BW/d (BPA 5, 10, or 40 groups) from GD11 to PND8 were monitored between days 19 and 30 for canalization
of the vagina; the day of complete canalization being considered to be vaginal opening (VO). An OIL-exposed group was used as a control. (A) Average age
at VO (presented as mean±SEM; n=15mice=group), and (B) percentage curves of VO are shown for each experimental group. (C,D) Gonadotropin levels
were assayed for each experimental group at different time points of postnatal development: PND12, 15, 18, 21, and 30. (C) LH and (D) FSH values are repre-
sented as the mean±SEM of 6–10 independent determinations. For VO data, **p<0:01, ***p<0:001 vs. corresponding OIL-exposed (control) group (one-
way ANOVA followed by Student-Newman-Keuls multiple range test). For hormonal data, *p<0:05, **p<0:01, ***p<0:001 vs. corresponding OIL-exposed
group for each age [one-way ANOVA followed by Fisher least significant difference (LSD) test]. ANOVA, analysis of variance; BPA, bisphenol A; BW, body
weight; FSH, follicle-stimulating hormone; GD, gestational day; LH, luteinizing hormone; PND, postnatal day; SE, standard error.
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following reagents in a final volume of 25 lL: 250 Ci [33P]-uridine
triphosphate (Perkin Elmer); 1 lg of template for Kiss1 or Tac2;
0:5mM rATP, rCTP, and rGTP; and 40 U T7 RNA polymerase.
Residual DNAwas digestedwith 4UDNase (Bio-Rad Laboratories),
and the reaction was terminated by the addition of 2 lL of 0:5 M
EDTA, pH 8.0. The riboprobes were separated from unincorporated
nucleotides using Illustra™ ProbeQuant™ G-50 MicroColums (GE
Healthcare).
Slides with mouse hypothalamic sections from the different
treatment groups and ages were processed before hybridization, as
described previously (Manfredi-Lozano et al. 2016). Briefly, slides
were a) fixed in paraformaldehyde at 4% for 15 min, b) stabilized
with 0:1 M phosphate buffer (pH 7.4) at room temperature for 20
min, c) acetylated for 10min in 0.25% acetic anhydride in 0:1 M tri-
ethanolamine to prevent nonspecific binding of probes, d) dehy-
drated in increasing concentrations of ethanol, e) delipidated with
chloroform, and f) air dried at room temperature for 1 h. After these
steps, hybridization with Kiss1 and Tac2 riboprobes was performed
during 16 h at 55°C. Hybridization solution contained deionized
formamide (SIGMA), 50% dextran sulfate (SIGMA), 5 M NaCl,
1 MTris base (pH 8.0), 0:5 MEDTA (pH 8.0), 50× Denhardt’s so-
lution (SIGMA), and 0:03 pmol=mL of radiolabeled ribo-probe
alongwith 10 mg=mLyeast tRNA (SIGMA).
The following day, slides were washed with 4× sodium sa-
line citrate (SSC) for 30 min, treated with RNase A (10 g=mL;
Sigma) for 30 min and washed under conditions of increasing
stringency including two 30-min washes in 0:1× SSC (1× SSC:
150 mM NaCl, 15 mM sodium citrate) at 65°C, dehydrated in
increasing ethanol series and air dried at room temperature for
1 h. Finally, slides were dipped in Kodak Autoradiography emul-
sion type NTB (Eastman Kodak), air dried, and stored at 4°C for
1 week in a dark room. After this period, the sections were devel-
oped and fixed following the manufacturer instructions (Kodak):
3-min in Kodak Dektol developer and 5 min in Kodak Fixer.
Slides were previously dehydrated and rinsed with Sub-X™
clearing medium and Sub-X mounting medium (SIGMA).
Figure 2. Impact of perinatal exposure to a range of doses of BPA on postnatal development of RP3V Kisspeptin neurons. (A) Immunohistochemical analyses
of Kp-IR structures. (B) The number of Kp-positive neurons were assayed in the RP3V of female mice perinatally exposed to BPA 5, 10, or 40 lg=kg BW/d
(BPA 5, 10, or 40 groups). An OIL-exposed group was used as a control. Quantitative data were collected for each experimental group at different age points
of postnatal development: PND12, 15, 18, 21, and 30, representative of the infantile, juvenile, and pubertal stages of postnatal maturation. (C) Representative
photomicrographs of RP3V Kp-positive neurons for OIL and BPA 5 groups at PND12, 15, 18, 21, and 30 are shown. The density of Kp-IR fibers, expressed as
fractional area (FA), and the number of Kp-positive neurons are represented as the mean±SEM of six serial sections of RP3V per animal (n=5 mice per
group). *p<0:05, **p<0:01 vs. corresponding OIL-exposed group for each age [one-way ANOVA followed by Fisher least significant difference (LSD) test].
ANOVA, analysis of variance; BPA, bisphenol A; BW, body weight; Kp-IR, kisspeptin-immunoreactive; PND, postnatal day; RP3V, rostral periventricular
area of the third ventricle; SE, standard error; 3V, third ventricle.
Environmental Health Perspectives 107011-5 127(10) October 2019
Quantification and Analysis of Kiss1 and Tac2 mRNA
Similar anatomical regions were analyzed using the mouse brain
atlas (Paxinos and Franklin 2001), and specific hybridization sig-
nals were quantified by densitometry using a digital imaging sys-
tem (Image-Pro® Plus 4.5; Media Cybernetics Inc.). Brain sections
were divided into five sets, composed of a total of 32–40 sections
each. For each set, sections were collected every 100 lm, with a
thickness of slice of 20 lm. For quantification, a single set was an-
alyzed unilaterally (adjacent sections at 100 lm intervals).
Hormone Measurements
Serum LH and FSH levels were measured in 25–50 lL aliquots,
using radioimmunoassay (RIA) kits supplied by the National
Institutes of Health (A.F. Parlow, National Hormone and Peptide
Program, Torrance, CA). Rat LH-I-10 and FSH-I-9 were labeled
with 125I using Iodo-gen tubes, following the instructions of the
manufacturer (Pierce Chemical Co.). Hormone concentrations
were expressed using reference preparations LH-RP-3 and FSH-
RP-2 as standards. For each sample, hormone measurements
were conducted in duplicate. Intra- and interassay coefficients of
variation were 8% and 10% for LH and 6% and 9% for FSH. The
sensitivity of the assay was 5 pg=tube for LH and 20 pg=tube for
FSH. Group sizes for hormonal determinations were 6–10 sam-
ples per group. Accuracy of hormone determinations was con-
firmed by assessment of mouse serum samples of known
concentrations (used as internal quality controls).
Presentation of Data and Statistical Analysis
Data are presented as means± standard error of themean ðSEMÞ.
Results were analyzed for statistically significant differences using
unpaired one-way analysis of variance (ANOVA) followed by
Fisher least significant difference (LSD) post hoc tests [SPSS soft-
ware (version 16; IBM)] or by Student-Newman-Keuls multiple
range test [Prism (version 6.0; GraphPad). In addition, Student’s
nonparametric t-test was used to assess variation among experimen-
tal groups (Prism). Values of p≤ 0:05were considered significant.
Figure 3. Impact of perinatal exposure to a range of doses of BPA on postnatal development of ARC Kisspeptin immunoreactivity. (A) Immunohistochemical
analyses of Kp-IR positive structures (fibers and cell bodies), expressed as fractional area (FA), were assayed in the ARC of female mice perinatally exposed
to BPA 5, 10, or 40 lg=kg BW/d (BPA 5, 10, or 40 groups). An OIL-exposed group was used as a control. Quantitative data were collected for each experi-
mental group at different time points of postnatal development: PND12, 15, 18, 21, and 30, representative of the infantile, juvenile, and pubertal stages of post-
natal maturation. (B) Representative photomicrographs of Kp-IR structures in ARC from OIL and BPA 5 groups at PND12, 15, 21, and 30 are shown. The
density of Kp-IR structures is represented as the mean±SEM of four serial sections of ARC per animal (n=5 mice per group). **p<0:01, ***p<0:001 vs. cor-
responding OIL-exposed group for each age [one-way ANOVA followed by Fisher least significant difference (LSD) test]. ANOVA, analysis of variance;
ARC, arcuate nucleus; BPA, bisphenol A; BW, body weight; Kp-IR, kisspeptin-immunoreactive; PND, postnatal day; SE, standard error.
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Results
Timing of PubertyOnset following Perinatal Exposure toBPA
The impact of BPA exposure on the age of VO was evaluated in
female mice perinatally exposed to increasing doses of BPA: 5,
10, or 40 lg=kg BW/d. All BPA doses induced a significant
advance in the mean age of VO compared with the control OIL
group (Figure 1A). This phenomenon was especially evident at
PND23, where all BPA 40-exposed animals already displayed
VO while no VO was observed in the OIL-exposed group
(Figure 1A). However, no dose–response effect was observed for
BPA impact on pubertal timing, as illustrated by the fact that the
age of VO was statistically similar between the groups exposed
to the lowest and the highest dose of BPA (Figure 1A).
Postnatal Secretion Patterns of LH and FSH following
Perinatal Exposure to BPA
Serum LH and FSH levels were assessed in the groups of female
mice perinatally exposed to increasing doses of BPA, at different
time points of postnatal development: PND12, 15, 18, 21, and 30,
representative of the infantile, juvenile, and pubertal stages of
postnatal maturation. Perinatal exposure to BPA resulted in sig-
nificantly lower serum LH levels at all ages and doses tested as
compared with the age-matched control animals, except for
PND18, when no significant differences were detected. In OIL-
exposed animals, LH levels fluctuated during the study period:
They were high at PND12, declined at PND15–18, and increased
before the onset of puberty at PND 21. However, serum levels of
LH were relatively constant and persistently low in all BPA-
exposed animals and ages tested (Figure 1B).
Regarding FSH secretion, variable but significant responses
to BPA exposure were only detected at PND15 and 18. Although
FSH secretion was higher in the BPA 5 and 10 groups versus the
OIL group at PND15, FSH levels were significantly lower in
these BPA groups at PND18 (Figure 1B). In contrast to develop-
mental LH responses to BPA exposure, fluctuations in circulating
levels of FSH were similar between OIL and BPA-exposed
groups, with a decline along postnatal development, especially
from early infantile (PND12 and 15) to late-infantile period
(PND18; Figure 1B). In addition, although significant differences
in LH and FSH levels were observed with various BPA doses
and time points, no dose–response effect was detected at any age.
Of note, early exposure to BPA 5, the lowest dose of BPA tested,
Figure 4. Impact of perinatal exposure to BPA 5 on postnatal expression of Kiss1 in the RP3V. Kiss1 mRNA levels in the RP3V were assessed by ISH in
female mice perinatally exposed to a low dose of BPA: 5 lg=kg BW/d (BPA 5 group). An OIL-exposed group was used as a control. (A) Quantitative Kiss1
mRNA expression data are presented at infantile (PND12, 15, 18), juvenile (PND21), and pubertal ages (PND30) for each experimental group (OIL and BPA
5). (B) The neuroanatomical area selected for quantitative analyses is displayed in the representative cartoon. (C) Representative photomicrographs of RP3V
Kiss1 mRNA expression for each experimental group at PND12, 15, 18, 21, and 30 are shown. Quantitative data of Kiss1 expression in the RP3V are presented
as the mean±SEM of the hybridization signals, obtained by densitometry, in individual sections from 5 different mice per group (A). *p<0:05, **p<0:01 vs.
corresponding OIL-exposed group for each age (Student’s nonparametric t-test). aca, anterior commissure, anterior part; AVPe, anteroventral periventricular
nucleus; BPA, bisphenol A; BW, body weight; ISH, in situ hybridization; Pe, periventricular hypothalamic nucleus; PND, postnatal day; RP3V, rostral periven-
tricular area of the third ventricle; SE, standard error; 3V, third ventricle.
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was sufficient to alter the pattern of gonadotropin secretion along
the postnatal development.
Postnatal Development of RP3V and ARC Kisspeptin
Neurons following Perinatal Exposure to BPA
Immunohistochemical analyses were conducted in female mice
perinatally exposed to the various doses of BPA, at the different
stages of postnatal development, in order to evaluate changes in
Kp-IR in the hypothalamic RP3V and ARC areas. Consistent
with previous studies, kisspeptin positive fibers and neurons were
detected at the RP3V and ARC in all control animals along the
study period (Clarkson and Herbison 2006). In the RP3V, Kp-IR
in control (OIL) animals, both in terms of fiber density and num-
ber of neurons, increased from early infantile period (PND12 and
15) to PND18 and remained high from PND18 to 30 (Figure 2;
see also Figure S2). A similar pattern of Kp-IR was also observed
in BPA-exposed animals. However, at PND30, the number of
both Kp-positive fibers and neuronal cell bodies was significantly
higher in BPA-treated groups, whereas the number of Kp-IR cells
was already significantly increased by perinatal BPA exposure, at
all doses, on PND12 and 21 (Figure 2; see also Figure S2).
In the ARC, an increase in Kp-IR fiber density was detected
along postnatal development in both control and BPA-exposed
mice. However, animals exposed to BPA showed a significantly
lower density of kisspeptin immuno-positive structures at all ages
as compared with controls, with a variable interaction between
the dose and age (Figure 3; see also Figure S3). Interestingly, the
lowest dose of BPA tested (BPA 5) was consistently associated
with a reduction in the total Kp-IR density at all ages studied,
except for PND18; this dose also altered Kp-IR in the RP3V,
both in terms of Kp fibers (at PND30) and number of Kp cells (at
PND12, 21, and 30) (Figure 2). Quantification of Kp-positive
neurons in the ARC was unviable due to the large amount of
fibers detected, which made it very difficult to discern between
kisspeptin positive fibers and cell bodies at this nucleus.
Postnatal Expression of Kiss1 mRNA in RP3V and ARC
following Perinatal Exposure to BPA 5
Considering the impact of the lowest dose of BPA on neuroana-
tomical distribution of Kp-IR along postnatal development, we
selected this experimental group for further quantitative ISH
analyses of Kiss1 mRNA expression at the R3PV and ARC of
Figure 5. Impact of perinatal exposure to BPA 5 on postnatal expression of Kiss1 in the ARC. Kiss1 mRNA levels in the ARC were assessed by ISH in female
mice perinatally exposed to a low dose of BPA: 5 lg=kg BW/d (BPA 5 group). An OIL-exposed group was used as a control. (A) Quantitative Kiss1 mRNA
expression data are presented at infantile (PND12, 15, 18), juvenile (PND21), and pubertal ages (PND30) for each experimental group (OIL and BPA 5). (B)
The neuroanatomical area selected for quantitative analyses is displayed in the representative cartoon. (C) Representative photomicrographs of ARC Kiss1
mRNA expression for each experimental group at PND12, 15, 18, 21, and 30 are shown. Quantitative data of Kiss1 expression in the ARC are presented as the
mean±SEM of the hybridization signals, obtained by densitometry, in individual sections from 5 different mice per group (A). **p<0:01 vs. corresponding
OIL-exposed group for each age (Student’s nonparametric t-test). ARC, arcuate nucleus; BPA, bisphenol A; BW, body weight; DM, dorsomedial nucleus;
ISH, in situ hybridization; PND, postnatal day; SE, standard error; VMH, ventromedial nucleus; 3V, third ventricle.
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infantile (PND12, 15, and 18), juvenile (PND21), and pubertal
(PND30) female mice. An increase in Kiss1 mRNA expression
during the juvenile–pubertal transition was observed at the R3PV
and ARC in all experimental groups (Figures 4 and 5). However,
perinatal BPA 5 exposure divergently impacted the profile of
Kiss1 expression at these two sites during postnatal maturation.
Thus, although BPA 5 females displayed significantly higher
Kiss1 mRNA levels than the control group in the RP3V at
PND12, 18, and 21 (Figure 4), a significant drop in Kiss1 mRNA
levels over the control group was observed at the ARC at all
ages, except for PND15, in BPA-treated animals (Figure 5).
Developmental Expression of Tac2 in the ARC following
Perinatal Exposure to BPA
Considering the proven co-expression of Kiss1 and Tac2 in the
ARC (Navarro et al. 2009a), and our findings on the Kiss1
mRNA expression profile in the ARC of BPA-exposed animals,
we selected two representative ages, PND15 (late infantile) and
PND30 (pubertal), to assess the impact of the range of doses of
BPA on the expression of Tac2 mRNA at the ARC. An increase
in Tac2 levels was detected in control females between the infan-
tile and pubertal ages (Figure 6), in line with previous references
(Navarro et al. 2012). Interestingly, perinatal exposure to a range
of doses of BPA was associated with a consistent drop of ARC
Tac2 levels at both ages tested, except for the BPA 10 dose at
PND15. In fact, at PND30, Tac2 expression levels in the ARC
were significantly lower in all BPA groups; perinatal BPA expo-
sure was able to substantially attenuate (BPA 5 and BPA 40) or
fully prevent (BPA 10) the developmental rise of Tac2 expres-
sion in the ARC detected in control animals (Figure 6).
Because the lowest dose of BPA, 5 lg=kg BW/d, was sufficient
to induce significant alterations in the expression of Tac2mRNA at
the ARC during the juvenile–pubertal transition, we used female
mice perinatally exposed to BPA 5 to conduct a detailed analysis of
the expression pattern of Tac2 mRNA at the ARC of infantile
(PND12, 15, and 18), juvenile (PND21), and pubertal (PND30) ani-
mals. In good agreement with Kiss1 mRNA profiles (Figure 5) and
our initial results (Figure 6), Tac2 mRNA levels increased along
pubertal development in the ARC of control and BPA-exposed
mice. However, perinatal exposure to BPA 5 was associated with a
significant suppression of Tac2mRNA expression, which was fully
Figure 6. Impact of perinatal exposure to a range of doses of BPA on developmental expression of Tac2 in the ARC. Tac2 mRNA levels in the ARC were
assessed by ISH in female mice perinatally exposed to BPA 5, 10, or 40 lg=kg BW/d (BPA 5, 10, or 40 groups). An OIL-exposed group was used as a control.
(A) Quantitative Tac2 mRNA expression data are presented at PND15 and 30 for each experimental group. (B) The neuroanatomical area selected for quantita-
tive analyses is displayed in the representative cartoon. (C) Representative photomicrographs of ARC Tac2 mRNA expression at PND15 and 30 for each ex-
perimental group are shown. Quantitative data of Tac2 expression in the ARC are presented as the mean±SEM of the hybridization signals, obtained by
densitometry, in individual sections from 5 different mice per group (A). **p<0:01, ***p<0:001 vs. corresponding OIL-exposed group for each age (one-way
ANOVA followed by Student-Newman-Keuls multiple range test). ANOVA, analysis of variance; ARC, arcuate nucleus; BPA, bisphenol A; BW, body
weight; DM, dorsomedial nucleus; ISH, in situ hybridization; PND, postnatal day; SE, standard error; VMH, ventromedial nucleus; 3V, third ventricle.
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detectable at the mid infantile (PND15), juvenile (PND21), and
pubertal (PND30) stages of postnatalmaturation (Figure 7).
Discussion
Puberty onset is highly sensitive to environmental promptings,
ranging from nutritional cues to hormone-mimics (Castellano and
Tena-Sempere 2016). Interest in pubertal alterations has been
boosted by recent worrying epidemiological reports of disturbed
puberty onset in humans (Aksglaede et al. 2009a; De Leonibus
et al. 2014; Herman-Giddens et al. 2012). Such perturbations
might, on one hand, serve as a sentinel for the deterioration of
environmental inputs onto reproductive health, and may, on the
other, have adverse long-term consequences, including higher
risk of different cancers as well as musculoskeletal, gynecologi-
cal, neurocognitive, and metabolic disorders (Day et al. 2015) to-
gether with reduced life expectancy (Lakshman et al. 2009). In
this context, the potential pubertal impact of BPA has been
addressed by numerous clinical and preclinical studies. Yet, con-
flictive results have been reported, possibly due to differences in
time windows, doses, and routes of exposure. Of note, most of
these studies a) did not provide a tenable substrate, or even the
neurohormonal or gonadal basis for the observed phenotypes,
and b) did not consider the pubertal impact of real-life BPA expo-
sure given that they involved the use of very high doses and more
invasive routes of administration (e.g., injections) that do not
match the expected patterns of environmental exposure.
In line with some previous studies (Adewale et al. 2009;
Fernández et al. 2009; Losa-Ward et al. 2012; Nikaido et al.
2004), our data show that early exposures to BPA can advance
VO as a consensus phenotypic sign of puberty onset. It must be
noted, however, that most of the previous studies consisted of ei-
ther exposures to high doses, in the range of >10- to 200-fold
higher than the present study (Nikaido et al. 2004), or parenteral
administration of the compound to the pups postnatally (Adewale
et al. 2009; Fernández et al. 2009; Losa-Ward et al. 2012) and
that the windows of exposure and doses are critically determinant
for the net impact of BPA on pubertal timing (Franssen et al.
2016). Our analyses document an intergenerational influence of
BPA, given orally to the mother over a range of doses, on puber-
tal timing of the female offspring, with a consistent advancement
of the age of VO in all BPA-treated groups. Notably, no dose
response was detected, and a trend for a nonmonotonic effect was
even observed given that the lowest and the highest BPA dose
appeared to impact the age of VO more than the intermediate
dose. Although we do not have a definitive explanation for this
Figure 7. Impact of perinatal exposure to BPA 5 on postnatal expression of Tac2 in the ARC. Tac2 mRNA levels in the ARC were assessed by ISH in female
mice perinatally exposed to a low dose of BPA: 5 lg=kg BW/d (BPA 5 group). An OIL-exposed group was used as a control. (A) Quantitative Tac2 mRNA
expression data is presented at infantile (PND12, 15, 18), juvenile (PND21), and pubertal ages (PND30) for each experimental group (OIL and BPA 5). (B)
The neuroanatomical area selected for quantitative analyses is displayed in the representative cartoon. (C) Representative photomicrographs of ARC Tac2
mRNA expression for each experimental group at PND12, 15, 18, 21, and 30 are shown. Quantitative data of Tac2 expression in the ARC are presented as the
mean±SEM of the hybridization signals, obtained by densitometry, in individual sections from 5 different mice per group. **p<0:01 vs. corresponding OIL-
exposed group for each age (Student’s nonparametric t-test). ARC, arcuate nucleus; BPA, bisphenol A; BW, body weight; DM, dorsomedial nucleus; ISH, in
situ hybridization; PND, postnatal day; SE, standard error; VMH, ventromedial nucleus; 3V, third ventricle.
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phenomenon, the fact that VO is a binary qualitative marker,
rather than a continuous variable, might have contributed to the
lack of dose responsiveness to BPA. In any event, this nonmono-
tonic relationship, which is frequently observed in other BPA
dose–response studies, seems to apply to other end points stud-
ied, such as gonadotropin levels, and has been previously related
to the induction of different ligand–receptor interactions (Villar-
Pazos et al. 2017). Importantly, the lowest dose tested (5 lg=kg
BW/d, between GD11 and PND8) is 10-fold below the tolerable
daily intake (TDI) proposed by the European Food Safety
Authority (EFSA) in 2006 and 1,000-fold lower than the no
observed adverse effect level (NOAEL) in humans (Picot et al.
2014). Even assuming the new recommendations of EFSA for a
temporary TDI of 4 lg=kg BW/d (EFSA Panel on Food Contact
Materials, Enzymes, Flavourings and Processing Aids 2015), the
lowest dose tested in our study is fully aligned with this tentative
precautionary value, which is nonetheless provisional and pend-
ing confirmation by a long-term BPA exposure study in rats
undertaken by the U.S. Food and Drug Administration (FDA).
All these features, together with the oral dosage, attest to the
potential environmental relevance of our findings.
Despite phenotypic signs for earlier pubertal maturation, peri-
natal BPA exposure resulted in a consistent suppression of circu-
lating LH levels, with a flattened pattern of secretion in all BPA
groups that was in clear contrast with the dynamic fluctuation of
endogenous LH levels seen in vehicle-treated prepubertal and
pubertal females. Assumedly, changes in LH levels likely reflect
changes in GnRH neurosecretory activity, therefore suggesting
that the pulsatile secretion of GnRH is suppressed after perinatal
exposure to BPA, even at low doses. This hypothesis is further
supported by the lower Kiss1 mRNA levels and kisspeptin con-
tent detected in the ARC of BPA-exposed mice; a Kiss1 neuronal
population that is regarded as a key element of the GnRH pulse
generator (Herbison 2016). Considering the more constitutive
and less-kisspeptin responsive pattern of secretion of FSH, the
fact that the secretory profiles of this gonadotropin were not
equally affected by BPA exposures is not surprising and may
help to reconcile the differential central versus peripheral impact
of BPA; the former was clearly inhibitory, whereas the later was
defined by an advancement of the age of VO. In any event, peri-
natal BPA might also operate as estrogenic compound directly at
the vaginal level, where it might contribute to its precocious ca-
nalization, which is known to be an estrogen-dependent phenom-
enon (Rodriguez et al. 1997).
Previous studies have evaluated the potential impact of BPA
on Kiss1/kisspeptin expression in the hypothalamus (Cao et al.
2012; Navarro et al. 2009b; Patisaul et al. 2009), although to our
knowledge no study addressing the effects of environmentally
relevant doses and routes of administration, and their impact on
puberty, had been reported so far. Moreover, some of these initial
studies lacked neuroanatomical resolution, which might explain
the divergent results showing that early BPA exposure, at high
doses, caused either a decrease (Navarro et al. 2009b) or an
increase (Xi et al. 2011), in whole hypothalamic Kiss1 expres-
sion. Interestingly, a protocol of perinatal exposure to BPA
grossly similar to ours was previously applied to evaluate the
capacity of this EDC to induce feminization of adult male rats in
terms of generation of the preovulatory surge of gonadotropins.
In that study, which did not address puberty, an expansion of the
RP3V population of Kiss1 neurons was documented in adult
male rats after perinatal dosage of BPA (Bai et al. 2011). In addi-
tion, oral administration of BPA either perinatally, to mouse
dams between G15 and PND21, or to adult female mice, at doses
in the range of those of this study, caused an increase in the num-
ber of kisspeptin neurons in the rostral hypothalamic area at
adulthood (Naulé et al. 2014; Wang et al. 2014). Our study nicely
complements those previous observations by showing for the first
time an expansion of the RP3V Kiss1 neuronal population during
the pubertal transition following developmental exposures to low
doses of BPA. The mechanism behind this consistent stimulatory
effect may be related to the proven ability of BPA to directly acti-
vate Kiss1 expression in vitro (Mueller and Heger 2014),
although it is equally tenable that BPA may mimic the ability of
endogenous estrogens to induce plastic changes in the RP3V
Kiss1 neuron population, causing its enlargement, as occurs dur-
ing normal puberty (Clarkson et al. 2009a).
Surprisingly, in contrast to the attention devoted to the impact
of BPA on the rostral population of Kiss1 neurons, little experi-
mental evidence has been produced regarding the potential
impact of this EDC on the ARC Kiss1 neuronal population, and
no information is available on its potential disruption at puberty.
One study reported that neonatal exposure to very high doses of
BPA (50 mg=kg BW), which is 10,000-fold higher than the low-
est dose used in our study, caused a reduction in kisspeptin-IR
fibers in adult female rats (Patisaul et al. 2009). Our study, using
a combination of analytical techniques for measurement, with an-
atomical resolution, of kisspeptin content (fibers) and Kiss1-
expressing neurons conclusively documents that, contrary to the
observed changes at the RP3V, there was a consistent suppres-
sion of the ARC Kiss1 neuronal population that was detectable
even at the lowest dose of BPA tested. In fact, quantitative analy-
ses by ISH revealed that such a suppression of Kiss1 was persis-
tently detectable from the infantile period to the pubertal stage. It
is well accepted that ARC Kiss1 neurons are sensitive to the in-
hibitory action of sex steroids, including estrogens, on Kiss1
expression (Marraudino et al. 2018; Pinilla et al. 2012; Smith
et al. 2005a, 2005b). Although the effects of perinatal BPA are
compatible with this action, it must be stressed that such an effect
was intergenerational given that BPA was administered to the
mothers (not to the pups) during a restricted time window, there-
fore suggesting potential developmental or organizing actions of
this EDC on the maturation of the population of ARC Kiss1 neu-
rons. Alternatively, early exposures to BPA may impact Kiss1
neurons, at least partially, via changes in gamma-amino aminobu-
tyric acid (GABA) neurotransmission because postnatal adminis-
tration of very low doses of BPA was recently shown to enhance
the GABAergic tone (Franssen et al. 2016), and GABA transmis-
sion to Kiss1 neurons has been reported in mice (DeFazio et al.
2014). This possibility, however, seems less feasible because the
effects of GABA on Kiss1 neurons seem to be transient or of
excitatory nature (DeFazio et al. 2014).
In good agreement with the observed changes in Kiss1 levels,
perinatal exposure to low doses of BPA caused a persistent sup-
pression of Tac2 expression in the ARC. Despite the relevance of
the Tac2-product, NKB, in the control of kisspeptin output and,
thereby, GnRH pulsatility (Navarro and Tena-Sempere 2011;
Pinilla et al. 2012), and the reported role of NKB signaling in the
control of puberty (Gill et al. 2012; Navarro et al. 2012), the puta-
tive effect of BPA on this tachykinin remained totally unex-
plored. Our data demonstrate that, at all doses tested, BPA was
able to blunt the levels of Tac2 detected in the ARC on PND30,
that is, at the time of puberty. This inhibitory effect was consis-
tently observed even for the lowest dose of BPA, at the infantile
(PND15), juvenile (PND21), and pubertal (PND30) stages of
postnatal maturation. Considering that NKB has been proposed
to operate as a stimulator of the kisspeptin output (Navarro and
Tena-Sempere 2011; Pinilla et al. 2012), whose increase in
expression actually precedes that of Kiss1 during pubertal matu-
ration (Navarro et al. 2012), our data open up the possibility that
changes in Tac2 levels in the ARC might mechanistically
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contribute to the dampening of Kiss1/kisspeptin expression
caused by perinatal BPA exposures in (pre)pubertal female mice.
Although much emphasis has been placed recently on the
trends for earliness in the timing of female puberty, detailed anal-
yses have suggested that the observed changes are likely toward
precocity for initial pubertal stages but toward lateness concern-
ing the final stages of pubertal maturation in both sexes (Parent
et al. 2016). Such a dichotomy, which has been considered to
illustrate the complex nature of the environmental influences on
the timing of puberty, is epitomized by our present findings that
show the divergent intergenerational impact of low doses of BPA
advancing the age of the initial sign of puberty onset in rodents,
namely VO, but consistently suppressing the ARC Kiss1/NKB
system and LH secretion, as a surrogate marker of GnRH neuro-
secretion, in pubertal female mice. These observations attest to
the translational relevance of our current data and call for the
application of precautionary measures concerning the prevention
of gestational/perinatal exposures even to low doses of BPA
given that they may disrupt key maturational events of the repro-
ductive axis such as puberty onset.
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